Xue Ji Bio

Xueji Bio is a China-based biotechnology company specializing in the discovery and development of targeted protein degradation (TPD) therapeutics, with a specific focus on molecular glue degraders. The company utilizes its proprietary X-Glue platform to design small molecules that facilitate the degradation of disease-causing proteins previously considered undruggable. Xueji Bio's research and development efforts are primarily concentrated on oncology and hematology, aiming to address significant unmet medical needs in these areas. Led by a team of industry veterans with deep expertise in medicinal chemistry and protein science, the company is advancing a pipeline of novel degraders toward clinical evaluation. Xueji Bio has secured significant venture capital backing from prominent investors to support its platform expansion and drug discovery programs.